Key things to know about how Elon Musk has boosted hard-right figures in Europe
Musk is a kingmaker on the platform he acquired in 2022 for $44 billion . He has used his influence to cultivate hard-right politicians and insurgent activists across Europe. A retweet or reply from Musk can lead to millions of views and tens of thousands of new followers, according to an Associated Press analysis of public data.
That fact has not been lost on influencers who have tagged Musk persistently, seeking a reply or a retweet. It has also fueled concerns in Europe about foreign meddling -- not from Russia or China, but from the United States.
'Every alarm bell needs to ring,' Christel Schaldemose, a vice president of the European Parliament who works on electoral interference and digital regulation, told AP.
The Associated Press analyzed more than 20,000 posts, which were compiled by Bright Data, over a three-year period from a sample of 11 European figures who had significant interactions with Musk and frequently promote a hard-right political or social agenda .
These case studies are not meant to be representative of a broad universe; rather they showcase the ways in which Musk's engagement can have an impact on local influencers that share his views.
Since acquiring Twitter in October 2022, Elon Musk's followers have more than doubled, to over 220 million. No other large account has shown such high or consistent growth.
The result: If Musk's X account is his megaphone, it has gotten a lot bigger since he took over -- a change that has global implications.
The accounts Musk has been promoting are part of a growing global alliance of nationalistic parties and individuals united in common cause to halt migration, overturn progressive policies and promote an absolutist vision of free speech, which has rattled the foundation of a trans-Atlantic bond that guided U.S. and European relations for over eight decades.
Several of the accounts AP analyzed belong to people who have faced allegations of illegal behavior in their own countries. Tommy Robinson, an anti-immigrant agitator in the U.K., was sentenced in October to 18 months in prison for violating a court order blocking him from making libelous allegations against a Syrian refugee. Bjoern Hoecke, a politician from Germany's Alternative for Deutschland (AfD) party, was convicted last year of knowingly using a Nazi slogan in a speech.
Italian vice premier Matteo Salvini was acquitted in December of allegations he illegally detained 100 migrants aboard a humanitarian rescue ship
Among the others examined by AP: Alice Weidel, who helped lead Germany's Alternative for Deutschland (AfD) party to its best electoral showing this year; Eva Vlaardingerbroek, a Dutch influencer known as the 'shieldmaiden of the far-right'; Naomi Seibt, a German activist dubbed the 'anti-Greta Thunberg' now living in what amounts to political exile in Washington DC; Rubén Pulido and Foro Madrid, both associated with Spain's populist Vox party; and Fidias Panayioutou, a politician from Cyprus who has also advocated for Musk's companies.
These accounts collectively gained roughly 5 million followers from the time Musk took over Twitter in October 2022 through January of this year. Most saw triple-digit percentage increases in their followers -- as high as 920%, or in one case of a tiny account exploding over that time, topping 6,000%. Even some accounts that grew more steadily on their own saw their follower counts sharply begin rising once Musk started interacting with them. Similarly, on days Musk interacted with a post, the number of views the account got soared — in most cases, accruing two to four times as many views, with a few seeing boosts 30 or 40 times their normal daily viewership.
More established players in Musk's orbit -- like Italian Prime Minister Giorgia Meloni, whose ruling Brothers of Italy party has neo-fascist roots — benefit less when Musk interacts with them on X, AP found.
Musk's dominance creates a strong incentive for people to get Musk to engage with their content.
Naomi Seibt, a German climate skeptic, pinged Musk nearly 600 times over the past three years. Musk finally engaged in June 2024, when he asked her to explain why the Alternative for Germany (AfD) party is so controversial in Germany.
Since then, Musk has replied to, quoted or tagged Seibt more than 50 times, and her followers have grown by more than 320,000 since Musk took over the platform. On days Musk interacted with Seibt, her posts, on average, got 2.6 times as many views.
'I didn't intentionally 'invade' Elon's algorithm,' Seibt told AP. 'Obviously Elon has a lot of influence and can help share a message even with those who are usually glued to the legacy media, particularly in Germany.'
Alice Weidel, who helps lead the Alternative for Germany (AfD) party, saw her daily audience surge from 230,000 to 2.2 million on days Musk interacted with her posts on X. After Musk hosted a livestream with Weidel on X, vice president JD Vance broke protocol and met her in Munich. Weidel's party, which is fighting a lawsuit to block the German government's decision to designate it as an extremist group, went on to secure its best electoral showing ever.
Musk has also used X to advocate for the leader of Italy's hard-right League party, Matteo Salvini. On days Musk interacted with Salvini's account, average views were more than four times higher than usual. Now serving as vice premier, Salvini has urged his government to move ahead with controversial contracts for Starlink and pushed back against European efforts to regulate content on X.
And Musk has a friend in Brussels: Fidias Panayiotou — a 25-year-old social media influencer from Cyprus. Before winning a surprise seat in the European Parliament last year, the Cypriot spent weeks on a quest to get Elon Musk to hug him. In January 2023, his wish came true. Their embrace went viral. Since taking office, Panayiotou has praised X on the floor of the European Parliament, pushed back against regulations that impact the platform, and credited Musk with sparking his call to fire 80% of EU bureaucrats.
Musk, evidently, was pleased. 'Vote for Fidias,' he wrote on X. 'He is smart, super high energy and genuinely cares about you!'
The endorsement has been viewed 11.5 million times.
—-
Kessler reported from Washington
—-
Contact AP's global investigative team at Investigative@ap.org or https://www.ap.org/tips/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Melania Trump opens application for performers looking to share their talents at the White House during Christmas
Melania Trump is searching for new talent to perform at the White House during the holiday season. The White House announced in a press release Monday that the First Lady and President Donald Trump have begun planning for their Christmas traditions. This includes inviting volunteers and performers to celebrate the holiday at the White House in Washington, DC. Melania is looking for talented musical groups — from school bands, choirs, and holiday-themed entertainers — to volunteer to perform in DC, according to the release. Performances will take place on eight specific dates in December during the holiday open houses at the White House. Applications to be a volunteer performer are open now until September 5 at 5 p.m. ET. Those interested must submit an audition tape either a capella or with an acoustic accompaniment. Amplification is not permitted. Anyone accepted to be a performer will be notified by October 13. In addition, Melania is looking for volunteers to help decorate the White House for the Christmas season. Any individual applying for this opportunity must be 18 or older, with decorating taking place from November 24 through November 30. However, both performers and decorating volunteers are responsible for their travel accommodations and personal expenses in DC. Along with open houses, the White House hosts a National Christmas Tree Lighting ceremony every year, with celebrities headlining. The 2024 event featured Adam Blackstone, Stephen Sanchez, and James Taylor, among others. During Donald Trump's first term in office, Melania made headlines for her holiday decorations when she opted for white branches instead of traditional Christmas trees in parts of the White House in 2017. Meanwhile, in 2018, her red trees were panned for appearing to be covered in blood. Years after Melania's Christmas decorations were mocked, Donald made it clear that he was still upset about the criticism. 'She would make the most beautiful Christmas decorations,' he said, while speaking at the First Baptist Church in Dallas, Texas, in 2021. 'And I remember she made these magnificent red trees, and the media said, 'Oh, that's terrible.' I said, 'Honey, next time, try white.'' 'She made magnificent, remember, the most beautiful you've ever seen, white trees? And they said, 'Oh, that's terrible.' I said the next time, let's do it more traditional. Let's go with green,' he added. 'We went with beautiful green trees, and they said: 'Why wouldn't you make them white like they used to be?' But I'll tell you what, she's loved all over, and she's got a tremendous heart.' Melania's Christmas spirit was also questioned in 2020 when she was heard on a leaked recording complaining about having to organize the decorations. The conversation was recorded in 2018 by a friend of Melania, Stephanie Winston Wolkoff. 'I'm working ... my a** off at Christmas stuff that you know, who gives a f*** about Christmas stuff and decoration?' Melania can be heard saying. 'But I need to do it, right? Correct?'
Yahoo
25 minutes ago
- Yahoo
Pharma CEOs downplay impact of tariffs amid rising cost concerns
Despite analyst warnings of heightened financial risk, pharma CEOs across the US and Europe remain confident that the latest US-EU trade deal and associated tariffs will have limited impact. As per a new deal between the two global economic powerhouses, the EU will pay the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, and the EU accounts for approximately 60% of all pharmaceutical imports to the US. Top-selling drugs such as AbbVie's Humira (adalimumab), MSD's Keytruda (pembrolizumab), and Novo Nordisk's Ozempic (semaglutide), for example, are manufactured in Europe and sent to the US, representing billion-dollar markets. Analysts from GlobalData's Pharma Strategic Intelligence team say that: 'Companies manufacturing pharmaceutical products in Europe will need to anticipate financial exposure when planning launches in the US due to the unfavourable gross to net dynamics, weakened pricing leverage with US payers, and slower commercial uptake as insurers reassess cost effectiveness due to the tariffs.' US President Donald Trump has had a sharp focus on the pharma industry since assuming office. Analysts predict that adding duties to incoming goods will likely elevate costs across the pharmaceutical value chain, ultimately raising drug prices for patients. The policies make for interesting analysis when combined with his desire to cut prescription prices in the country. Diederik Stadig, sector economist for TMT & healthcare at ING, wrote in a July note: 'A tariff would hurt consumers most of all, as they would feel the inflationary effect of tariffs directly when paying for prescriptions.' The European Federation of Pharmaceutical Industries and Associations (EFPIA), for example, has maintained that tariffs on medicines are ineffective. The group says such policies only hinder patient access to medicines. GlobalData also forecasts disruptions to launch planning, particularly late-stage assets with EU-based manufacturing and production planned for entry into the US. R&D budgets of pharmaceutical companies are already under pressure and the firefighting of tariffs could place additional strain on resources. CEOs signal resilience CEOs of big pharma companies, however, are maintaining a brave face despite the projected headwinds. The UK-EU trade deal announcement arrived in the middle of the pharma industry's Q2 reporting period, where execs were pressed on financial outlooks. In a Q2 earnings call, AbbVie's CEO Rob Michael said the US company is 'fairly insulated' from any tariff-related impacts in 2025, though caveated that the company would not speculate on the longer-term consequences. AstraZeneca shared the same sentiment. CEO Pascal Soriot said the British-Swedish drugmaker is 'almost self-sufficient in terms of supply,' adding that 'tariffs is not an issue that is really affecting us very much.' However, AstraZeneca is on a long list of pharma companies transferring manufacturing to the US. This includes a $4bn investment to build a new manufacturing plant in Virginia. Sanofi has outlaid $20bn to bolster US manufacturing through 2030 and Roche unveiled a similar $50bn investment strategy, to name just a couple. The team at GlobalData added: 'Ultimately, the recent US-EU trade deal has increased the level of uncertainty within the pharmaceutical industry, raising concerns on the potential of tariffs increasing past 15% in the future. 'While the full impact will take time to unfold, it will be interesting to see the adoption of different strategies on how the pharmaceutical industry looks to balance innovation, and ensuring patient access, while managing the pressures of tariffs as they unfold into a certain reality.' A critical part of the industry's future also relies on the outcome of the US government's Section 232 investigation into the drug sector. The probe, which Trump initiated to evaluate the role of medicine imports on national security, could result in further tariffs being imposed. MSD CEO Rob Davis said in the company's Q2 earnings call: 'We need to see more clarity both from the administration and just overall as to how exactly [the 15% tariff] is going to play out. It's still not clear exactly how this relates relative to the February investigation and the timing of whether these apply now or will be phased in until there's further guidance.' AbbVie's Michael said: 'We're having constructive discussions with the administration on sectoral tariffs. Clearly, the best way to motivate that is through tax incentives as well as a trade agenda that prioritises innovation. We're well positioned as a company, but we're not going to be able to really give you any details until we understand the outcome of the 232 investigation.' Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "Pharma CEOs downplay impact of tariffs amid rising cost concerns" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
CNN
27 minutes ago
- CNN
Ukraine is now Trump's war
Donald Trump Russia War in UkraineFacebookTweetLink Follow Vladimir Putin started it. Joe Biden didn't stop it. But, no matter his efforts to the contrary, this is the week in which Russia's invasion of Ukraine becomes US President Donald Trump's war. The most powerful office in the world doesn't always invite choices. Trump is mandated to address the biggest conflict in Europe since World War II because the United States was involved, under his predecessor, as Ukraine's key ally and sponsor. Trump could have dropped the war entirely. But instead, he chose to impose the force of his personality, initially through the idea he could end it in 24 hours, or a revised deadline of 100 days. Then he tried to navigate its personalities, cozying up to the Russian president initially, echoing his narratives and then berating Ukrainian President Volodymyr Zelensky publicly in the Oval Office. He hit his NATO allies hard, demanding they pay more for Europe's defense, which they did. And then the hard slog of diplomacy sputtered into gear, ultimately yielding very little. But it is in the last fortnight that Trump's decisions – and realizations – have turned this into a problem he now owns. He has seen Putin does not want peace. He has seen Ukraine urgently needs arms, and he tried to help, albeit in a lackluster way. He made the remarkable choice of responding to the usually dismissed nuclear saber-rattling of former Russian President Dmitry Medvedev, with harder nuclear threats about positioning US nuclear submarines closer to Russia. The US went from pausing military aid to Ukraine to threatening nuclear force against Russia in less than a month. As this week ends, with Trump's shortened deadline for a peace deal coming into view, he must make perhaps the most consequential decision of the conflict yet. Does he impose penalties – secondary tariffs against Russia's energy customers – that really hurt? Does he accept the US and its allies might need to endure a little pain economically, to inflict pain? Imposing serious secondary sanctions on India and China could roil the global energy market. Trump posted Monday he would be increasing tariffs on India because it was selling Russian crude on at a profit, and he didn't 'care how many people are being killed by the Russian War Machine,' although he did not provide details as to the new measures. India has not made it publicly clear if it intends to stop buying Russian energy products. China is utterly dependent on Russian oil and gas and simply cannot afford to stop buying it. CNN's Nick Paton Walsh describes the riveting escape plan hatched by Ukrainian forces to save the life of an injured soldier pinned down by Russian attacks. To avoid another a 'TACO' moment – short for Trump Always Chickens Out – Trump will have to cause some discomfort and will likely feel some back. Or he can look for an off-ramp, if one is offered to his special envoy Steve Witkoff in an expected Moscow visit this week. Trump could perhaps accept a bilateral meeting with Putin as a sign of progress toward peace. But even this backing down would still mean he has left his indelible imprint on the war – that, in the words of former US Secretary of State Colin Powell regarding Iraq, if the United States breaks it, they own it. Trump cannot have it both ways. It is in his nature to seek to be the fulcrum of all decisions, and the lightning rod of attention, on any given issue. Every turning point so far has been based around his personal choice and fancy. And with this comes a key lesson of the American presidency. Trump does not get to choose which problems are his, and which he can ignore. MAGA's America First platform may be about reducing Washington's global footprint, but it doesn't permit Trump to own solely his successes – and not his failures. Unless Trump reduces the footprint of American power globally to zero – incompatible with a presidential personality compelled to 'do' and agitate – there will always be some problems that are America's. He says he wants wars to stop. But that is not enough in itself. The wars have not all complied. Former US President Barack Obama inherited wars in both Iraq and Afghanistan. He ducked fast out of the former, and doubled down with a surge in the latter, which did not work. Afghanistan became Obama's war, even though it was a mess he had inherited. Trump in turn was passed that mess, and he handed his quick fix to Biden to execute, in the chaotic collapse of August 2021, widely paraded by Republicans as a Democrat failing. Trump faces the same problem of inheriting a crisis. He cannot wish or cajole the conflict to an end. The very battlefield deaths he mourns have sewn damage and grief afar, turning this into an existential war of survival for the Kremlin, and for the soul of Ukrainian society. Ukrainians want to live in peace, without nightly air raid sirens. Putin does not want peace, and instead his most recent maximalist demands amount to something tantamount to Ukrainian surrender. Ultimately, it is reflection of a harsh reality that this should be seen as Trump's war. It is the defining conflict of his presidency and of the post-9/11 era. Its outcome defines European security and Chinese belligerence over the next decade. China understands that and needs Russia to win. Europe understands that, and is arming itself so Russia does not see opportunity in the bloc's weakness. Whether Trump understands this and accepts discomforting, strident decisions with the consequences that follow, we will learn in the week ahead.
